The NCCN. Invasive breast cancer: Clinical practice guidelines in oncology™ Journal Article
| Authors: | Carlson, R. W.; Anderson, B. O.; Burstein, H. J.; Carter, W. B.; Edge, S. B.; Farrar, W. B.; Goldstein, L. J.; Gradishar, W. J.; Hayes, D. F.; Hudis, C. A.; Jahanzeb, M.; Ljung, B. M.; Kiel, K.; Marks, L. B.; McCormick, B.; Nabell, L. M.; Pierce, L. J.; Reed, E. C.; Silver, S. M.; Smith, M. L.; Somlo, G.; Theriault, R. L.; Ward, J. H.; Winer, E. P.; Wolff, A. C. |
| Article Title: | The NCCN. Invasive breast cancer: Clinical practice guidelines in oncology™ |
| Abstract: | The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. In many situations, the patient and physician are responsible for jointly exploring and selecting the most appropriate option from among the available alternatives. With rare exceptions, the evaluation, treatment, and follow-up recommendations in these guidelines are based on the results of past and present clinical trials. However, not a single clinical situation exists in which the treatment of breast cancer has been optimized with respect to either maximizing cure or minimizing toxicity and disfigurement. Therefore, patient and physician participation in prospective clinical trials allows patients to not only receive state-of-the-art cancer treatment but also contribute to improving the treatment of future patients. © Journal of the National Comprehensive Cancer Network. |
| Keywords: | clinical trial; pathogenesis; review; bevacizumab; doxorubicin; fluorouracil; area under the curve; monotherapy; unspecified side effect; antineoplastic agents; united states; capecitabine; gemcitabine; paclitaxel; adjuvant therapy; cancer radiotherapy; chemotherapy, adjuvant; chemotherapy; methotrexate; cancer staging; antineoplastic agent; neoplasm staging; clinical practice; carboplatin; unindexed drug; multiple cycle treatment; breast cancer; radiation; mastectomy; radiotherapy; aromatase inhibitor; combination chemotherapy; nccn clinical practice guidelines; cyclophosphamide; practice guideline; continuous infusion; pathology; breast neoplasms; oncology; cancer mortality; docetaxel; exemestane; cancer invasion; drug antagonism; adjuvant chemotherapy; cardiotoxicity; vitamin d; breast tumor; brachytherapy; tamoxifen; epirubicin; lung carcinoma; neoplasm invasiveness; hormonal therapy; hot flush; letrozole; trastuzumab; anastrozole; navelbine; recombinant granulocyte colony stimulating factor; anthracycline; venlafaxine; patient attitude; citalopram; fluoxetine; paroxetine; paget nipple disease; therapy; antiestrogen; segmental mastectomy; mastectomy, segmental; zoledronic acid; endocrine therapy; ductal carcinoma in situ; lobular carcinoma in situ; carcinoma, ductal, breast; carcinoma, lobular; breast-conserving therapy; pamidronic acid; practice guidelines; citrate calcium |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 5 |
| Issue: | 3 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2007-03-01 |
| Start Page: | 246 |
| End Page: | 312 |
| Language: | English |
| PUBMED: | 17439758 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 20" - "Export Date: 17 November 2011" - "Source: Scopus" |
Citation Impact
Related MSK Work